D5BI:XETRA:XETRA-Xtrackers MSCI Mexico UCITS ETF 1C (EUR)

ETF | Others |

Last Closing

USD 5.176

Change

-0.01 (-0.14)%

Market Cap

USD 0.27B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.13 (+0.25%)

USD 426.26B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.05 (+0.28%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.01 (-0.04%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.04 (+0.12%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.01 (+0.04%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.13 (-0.29%)

USD 104.42B
8R80:XETRA Amundi Index Solutions - Amund..

+0.30 (+0.21%)

USD 104.42B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.14 (+0.27%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.10 (-0.10%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.58 (-0.26%)

USD 80.38B

ETFs Containing D5BI:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -21.33% 4% F 9% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return -21.33% 4% F 8% B-
Trailing 12 Months  
Capital Gain -13.33% 4% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -13.33% 4% F 10% F
Trailing 5 Years  
Capital Gain 30.25% 57% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 30.25% 52% F 54% F
Average Annual (5 Year Horizon)  
Capital Gain 18.84% 92% A 88% B+
Dividend Return 18.84% 91% A- 88% B+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 18.25% 23% F 36% F
Risk Adjusted Return 103.20% 95% A 95% A
Market Capitalization 0.27B 52% F 46% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.